https://www.taxtmi.com/caselaws?id=107283 The court ruled in favor of the appellants, emphasizing the importance of aligning tax valuation methods with established commercial practices in the pharmaceutical industry. The judgment rejected the Revenue's argument against batch-wise valuation of medicines subject to Maximum Retail Price, stating that such valuation was consistent with the Drug (Control) Law and industry norms. The court highlighted the need for certainty and stability in tax administration, ultimately setting aside the impugned orders and allowing the appeals. en-us Thu, 27 Feb 2003 00:00:00 +0530 Wed, 21 Mar 2012 12:22:48 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=107283 The court ruled in favor of the appellants, emphasizing the importance of aligning tax valuation methods with established commercial practices in the pharmaceutical industry. The judgment rejected the Revenue's argument against batch-wise valuation of medicines subject to Maximum Retail Price, stating that such valuation was consistent with the Drug (Control) Law and industry norms. The court highlighted the need for certainty and stability in tax administration, ultimately setting aside the impugned orders and allowing the appeals. Case-Laws Central Excise Thu, 27 Feb 2003 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=107283